glp-1 epilepsy Association Between Receptor Agonist Use and Risk in Type 2 Diabetes Seizure Recurrence after GLP-1 Receptor

Additionally, GLP-1RAs reduce the expression of several pro-inflammatory cytokines, including IL-2, IL-17a, IL-6, IFN, and TNF [20,21,24,25]

Psychiatry 22 , 13761384 (2017)

Response options included yes, significantly

What deserves careful thought before starting: compounded medications are not FDA-approved, the regulatory environment for compounded GLP-1s is actively shifting as of mid-2026 with a live FDA comment period closing June 29, consultation fees are non-refundable once incurred, and prescription approval is not guaranteed

Androgen Levels: These medications lower testosterone levels, reducing symptoms like hirsutism and acne

Here is the critical detail that many people miss